Centrus Energy CORP 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
Centrus Energy Corp. and Oklo, Inc. have signed definitive multi-year contracts for high-assay low-enriched uranium (HALEU), with Oklo making prepayments to support Centrus's domestic enrichment capacity expansion.
NYSE
Centrus Energy Corp. announced the appointment of Kevin Graney to its Board of Directors, effective November 4, 2026, bringing extensive experience in nuclear technology and advanced manufacturing.
NYSE
Centrus Energy Corp. announced third quarter 2026 results, reporting a GAAP net income of $31.6 million, while also achieving key milestones in centrifuge manufacturing and supply chain finalization ahead of schedule.
NYSE
Centrus Energy has completed and shipped its first new centrifuge from its Oak Ridge plant, marking a key step in its multi-billion-dollar uranium enrichment capacity expansion.
NYSE
Centrus Energy Corp. has acquired Westerman Holdings, LLC for approximately $116 million, integrating a key supplier to bolster supply chain resilience and diversify its manufacturing and revenue base.
NYSE
Centrus Energy Corp. has signed a multi-year contract with Antares Nuclear to supply High-Assay Low-Enriched Uranium (HALEU), with deliveries starting before the end of the decade.
NYSE
Centrus Energy Corp. announced the pricing of its underwritten public offering of common stock and warrants, raising approximately $500 million to fund general working capital and corporate purposes.
NYSE
Centrus Energy Corp. has signed a multi-year contract with Radiant Industries, Inc. to supply High-Assay Low-Enriched Uranium (HALEU) for Radiant's Kaleidos microreactors, with deliveries starting before the end of the decade.
NYSE
Centrus Energy Corp. announced a special grant of performance-based restricted stock units (Performance RSUs) to executive officers and senior leaders, tied to achieving specific production and cost milestones.
NYSE
Centrus Energy Corp. has signed a definitive contract with X-energy, LLC to supply low enriched uranium (LEU) and high-assay low-enriched uranium (HALEU), bolstering the U.S. nuclear fuel supply chain.
NYSE
Centrus Energy announced robust second quarter 2026 results, highlighted by significant commercial achievements in High-Assay, Low-Enriched Uranium (HALEU) and a substantial increase in revenue.
NYSE
Centrus Energy Corp. has signed a significant $900 million contract with the U.S. Department of Energy to establish commercial High-Assay, Low-Enriched Uranium (HALEU) production capacity.
NYSE
Centrus Energy Corp. has amended its Section 382 Rights Agreement, extending its expiration date and increasing the purchase price to preserve valuable net operating loss carryforwards.
NYSE
Centrus Energy Corp. and Oklo, Inc. have signed a non-binding letter of intent for Centrus to supply high-assay, low-enriched uranium (HALEU) starting in 2029 to fuel Oklo's planned Aurora powerhouses.
NYSE
Centrus Energy Corp. announced first quarter 2026 financial results, reporting revenue of $76.7 million and raising full-year revenue guidance.
NYSE
Centrus Energy Corp. has chosen Geiger Brothers, Inc. as the construction contractor for its multi-billion-dollar uranium enrichment facility expansion in Piketon, Ohio.
NYSE
Centrus Energy Corp. has adopted Fourth Amended and Restated Bylaws, clarifying voting standards, implementing universal proxy rules, and establishing exclusive forum provisions for legal disputes.
NYSE
Centrus Energy's subsidiary, American Centrifuge Operating, LLC, has partnered with Fluor Federal Services, Inc. for the engineering, procurement, and construction of its commercial uranium enrichment facility expansion in Piketon, Ohio.
NYSE
Centrus Energy Corp. announced robust full-year 2025 financial results, including increased revenue and net income, alongside a significant $900 million HALEU production award from the U.S. Department of Energy.
NYSE
Centrus Energy Corp. announced a major expansion of its Oak Ridge facility, investing over $560 million and creating nearly 430 jobs to boost domestic uranium enrichment capabilities.
NYSE
Centrus Energy has commenced domestic centrifuge manufacturing to support a multi-billion-dollar uranium enrichment expansion, aiming to meet a $2.3 billion sales backlog and create thousands of U.S. jobs.
NYSE
Centrus Energy Corp. announced its Class A Common Stock and associated rights will transfer from NYSE American to the New York Stock Exchange, effective December 4, 2025.
NYSE
Centrus Energy Corp. announced a new at-the-market equity offering program to sell up to $1 billion in Class A common stock for general corporate purposes.
NYSE
Centrus Energy Corp. reported a net income of $3.9 million for Q3 2025, a significant improvement from a net loss in the prior year, driven by increased revenue and a strengthened balance sheet from a convertible notes offering.
NYSE
Centrus Energy announced plans for a multi-billion-dollar expansion of its Piketon, Ohio uranium enrichment plant, contingent on federal funding, aiming to create 1,300 jobs and boost domestic LEU and HALEU production.
NYSE
Centrus Energy signed a non-binding MOU with Korea Hydro & Nuclear Power and POSCO International to explore investment for its Ohio uranium enrichment plant expansion and increased LEU supply.
NYSE
Centrus Energy Corp. announced the resignation of its CFO, Kevin J. Harrill, and board member Stephanie O'Sullivan, detailing Harrill's separation package.
NYSE
Centrus Energy Corp. obtains full DOE waiver for Russian low enriched uranium imports through 2027, ensuring supply for U.S. customers.
NYSE
Centrus Energy Corp. has issued $805 million in 0% Convertible Senior Notes due 2032 to fund general corporate purposes.
NYSE
Centrus Energy Corp. announced the pricing of an upsized $700 million private offering of 0% convertible senior notes due 2032 to qualified institutional buyers.